| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.43 | 0.002 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |